In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results.

MLA

Gianotti, N., et al. “In Vivo Dynamics of the 103N Mutation Following the Withdrawal of Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients: Preliminary Results.” The New Microbiologica, vol. 27, no. 2 Suppl 1, Apr. 2004, pp. 111–17. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15646073&authtype=sso&custid=ns315887.

APA

Gianotti, N., Boeri, E., Maillard, M., Serra, G., Ratti, D., Gallotta, G., Vacchini, D., Tremolada, Y., & Castagna, A. (2004). In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results. The New Microbiologica, 27(2 Suppl 1), 111–117.

Chicago

Gianotti, N, E Boeri, M Maillard, G Serra, D Ratti, G Gallotta, D Vacchini, Y Tremolada, and A Castagna. 2004. “In Vivo Dynamics of the 103N Mutation Following the Withdrawal of Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients: Preliminary Results.” The New Microbiologica 27 (2 Suppl 1): 111–17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15646073&authtype=sso&custid=ns315887.